TABLE 3.
SNPs HIGHLY ASSOCIATED WITH CIRCULATING CC16 LEVELS AND SP-D LEVELS OF SUBJECTS WITH COPD
SNP | Rank | P | CHR | Coordinate | Type | Closest Gene | Distance to Gene | Minor Allele | MAF | HWE | |
CC16 | rs3741240 | 1 | 1.42 × 10−26 | 11 | 62186542 | 5′ UTR | SCGB1A1 | 0 | A | 0.36 | 0.05 |
rs2077224 | 2 | 1.67 × 10−14 | 11 | 62197427 | Downstream | AHNAK | 3,589 | A | 0.38 | 0.63 | |
rs2509956 | 3 | 1.03 × 10−13 | 11 | 62196723 | Downstream | AHNAK | 4,293 | C | 0.37 | 0.96 | |
rs10836312 | 4 | 6.72 × 10−11 | 11 | 34810443 | Intergenic | APIP | 93,402 | C | 0.41 | 0.93 | |
rs2463822 | 5 | 1.02 × 10−10 | 11 | 62103420 | Upstream | ASRGL1 | −1,354 | T | 0.12 | 1 | |
rs906902 | 6 | 2.42 × 10−10 | 11 | 34780278 | Intergenic | EHF | 97,197 | A | 0.40 | 0.82 | |
rs10466455 | 7 | 2.63 × 10−10 | 11 | 34780936 | Intergenic | EHF | 97,855 | C | 0.40 | 0.85 | |
rs2463836 | 8 | 3.11 × 10−10 | 11 | 62126494 | Intronic | ASRGL1 | 0 | A | 0.12 | 1 | |
rs2246920 | 9 | 3.48 × 10−10 | 11 | 62104937 | Regulatory region; 5′ UTR | ASRGL1 | 0 | T | 0.12 | 1 | |
rs17157266 | 10 | 1.29 × 10−09 | 11 | 62199817 | Downstream | AHNAK | 1,199 | C | 0.18 | 0.07 | |
rs7929679 | 11 | 7.26 × 10−09 | 11 | 34805849 | Intergenic | APIP | 97,996 | G | 0.49 | 0.72 | |
SP-D | rs1885551 | 1 | 1.16 × 10−39 | 10 | 81712353 | Intronic | SFTPD | 0 | G | 0.10 | 0.39 |
rs2146192 | 2 | 1.16 × 10−39 | 10 | 81715738 | Intronic | SFTPD | 0 | C | 0.10 | 0.39 | |
rs7084667 | 3 | 1.14 × 10−29 | 10 | 81748708 | Intergenic | SFTPD | −5,712 | T | 0.34 | 0.72 | |
rs3923564 | 4 | 1.76 × 10−27 | 10 | 81735981 | Intronic | SFTPD | 0 | G | 0.04 | 1 | |
rs1885553 | 5 | 5.33 × 10−21 | 10 | 81711711 | Intronic | SFTPD | 0 | C | 0.33 | 0.69 | |
rs1932571 | 6 | 5.37 × 10−20 | 10 | 81761489 | Intergenic | RP11-369J21.6 | 15,944 | T | 0.18 | 0.22 | |
rs7905482 | 7 | 8.37 × 10−15 | 10 | 81863964 | Intergenic | RP11-369J21.2 | 11,651 | T | 0.36 | 0.30 | |
rs911887 | 8 | 7.15 × 10−14 | 10 | 81701523 | Intronic | SFTPD | 0 | C | 0.42 | 0.75 | |
rs12778754 | 9 | 2.19 × 10−13 | 10 | 81869642 | Intergenic | RP11-369J21.4 | −16,055 | A | 0.31 | 0.27 | |
rs8048576 | 10 | 8.96 × 10−13 | 16 | 84423034 | Intronic | ATP2C2 | 0 | A | 0.12 | 0.92 | |
rs728616 | 11 | 2.02 × 10−12 | 10 | 81847914 | Intronic | RP11-369J21.2 | 0 | T | 0.08 | 0.75 | |
rs3851050 | 12 | 1.27 × 10−11 | 10 | 81882370 | Upstream | RP11-369J21.4 | −3,327 | C | 0.41 | 0.43 | |
rs1265110 | 13 | 2.76 × 10−11 | 6 | 31119422 | Intronic | CCHCR1 | 0 | T | 0.11 | 0.49 | |
rs12220777 | 14 | 6.69 × 10−11 | 10 | 81788104 | Upstream | RP11-369J21.5 | −3,189 | C | 0.08 | 7.3 × 10−6 | |
rs6585424 | 15 | 1.38 × 10−10 | 10 | 81933748 | Intronic | ANXA11 | 0 | G | 0.13 | 0.48 | |
rs6585454 | 16 | 1.38 × 10−10 | 10 | 81940701 | 5′ UTR | ANXA11 | 0 | G | 0.13 | 0.48 | |
rs8063863 | 17 | 1.56 × 10−10 | 16 | 84400850 | Upstream | ATP2C2 | −1,283 | T | 0.15 | 0.41 | |
rs2074488 | 18 | 2.28 × 10−10 | 6 | 31240431 | Upstream | HLA-C | −524 | T | 0.13 | 0.85 | |
rs9266629 | 19 | 3.99 × 10−10 | 6 | 31346822 | Upstream | FGFR3P | 1,026 | C | 0.21 | 0.11 | |
rs11201799 | 20 | 1.44 × 10−09 | 10 | 81881954 | Upstream | RP11-369J21.4 | −3,743 | A | 0.09 | 0.40 | |
rs7078012 | 21 | 4.95 × 10−09 | 10 | 81705433 | Intronic | SFTPD | 0 | T | 0.13 | 0.06 | |
rs1923539 | 22 | 5.03 × 10−09 | 10 | 81694950 | Within noncoding gene | RP11-479O17.4 | 0 | A | 0.25 | 0.60 | |
rs1265093 | 23 | 5.78 × 10−09 | 6 | 31107187 | Intronic | PSORS1C1 | 0 | A | 0.26 | 0.27 | |
rs3130559 | 24 | 8.34 × 10−09 | 6 | 31097301 | Intronic | PSORS1C1 | 0 | T | 0.20 | 0.63 |
Definition of abbreviations: CC16 = Clara cell secretory protein; CHR = chromosome; COPD = chronic obstructive pulmonary disease; HWE = P value for deviation from Hardy-Weinberg equilibrium; MAF = minor allele frequency; SNP = single nucleotide polymorphisms; SP-D = surfactant protein D.